Last $0.22 USD
Change Today +0.0088 / 4.19%
Volume 100.0
INNV On Other Exchanges
As of 8:10 PM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

innovus pharmaceuticals inc (INNV) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/13/14 - $0.93
52 Week Low
07/8/14 - $0.11
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

innovus pharmaceuticals inc (INNV) Related Businessweek News

No Related Businessweek News Found

innovus pharmaceuticals inc (INNV) Details

Innovus Pharmaceuticals, Inc., a pharmaceutical company, is engaged in the commercialization, licensing, and development of non-prescription pharmaceutical and consumer health products in the United States and internationally. Its male and female sexual health and vitality products include EjectDelay, an over-the-counter monograph-compliant benzocaine-based topical gel for treating premature ejaculation; CIRCUMserum, a non-medicated cream to alleviate reduced penile sensitivity; Zestra, a non-medicated patented natural product to increase desire and arousal, and reduce pain from sexual intercourse in women; and Zestra Glide, a clinically tested water-based longer lasting lubricant. The company also provides pain management products comprising Apeaz, an OTC monograph-compliant topical cream for the relief of arthritis pain; and Xyralid, an OTC monograph compliant lidocaine-based spray in development for the relief of hemorrhoids. It markets its products directly or through commercial partners to primary care physicians, urologists, gynecologists, and therapists; and directly to consumers through on-line channels, retailers, and wholesalers. Innovus Pharmaceuticals, Inc. is based in San Diego, California.

2 Employees
Last Reported Date: 03/28/14

innovus pharmaceuticals inc (INNV) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: --
Compensation as of Fiscal Year 2013.

innovus pharmaceuticals inc (INNV) Key Developments

Innovus Pharmaceuticals, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015

Innovus Pharmaceuticals, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015 . Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States.

Innovus Pharmaceuticals, Inc. Expands Agreement with Tramorgan Limited to Commercialize Vesele in the United Kingdom

Innovus Pharmaceuticals, Inc. announced it has expanded its exclusive marketing and distribution agreement with Tramorgan Limited, and granted to Tramorgan additional rights to market and sell Innovus Pharma's oral dietary supplement to promote sexual and cognitive health, Vesele in the United Kingdom. Under the agreement, Innovus is eligible to receive up to $13 million dollars in sales milestone payments plus 50% royalties based on Tramorgan's sales of Vesele in the UK. The product will be available in a 120 capsule bottle and will be priced at $26.50 per bottle online and $32.00 in retail stores.

Innovus Pharmaceuticals, Inc. Presents at LD Micro Conference, Dec-02-2014 02:30 PM

Innovus Pharmaceuticals, Inc. Presents at LD Micro Conference, Dec-02-2014 02:30 PM. Venue: Luxe Sunset Boulevard Hotel, 11461 Sunset Boulevard, Los Angeles, California, United States.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INNV:US $0.22 USD +0.0088

INNV Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for INNV.
View Industry Companies

Industry Analysis


Industry Average

Valuation INNV Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 7.3x
Price/Book 308.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 7.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INNOVUS PHARMACEUTICALS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at